Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kairos Pharma (KAPA) Asset Utilization Ratio (2024 - 2025)

Kairos Pharma's Asset Utilization Ratio history spans 2 years, with the latest figure at 22.7 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 147.37% year-over-year to 22.7; the TTM value through Dec 2025 reached 22.7, up 147.37%, while the annual FY2025 figure was 8.12, N/A changed from the prior year.
  • Asset Utilization Ratio reached 22.7 in Q4 2025 per KAPA's latest filing, up from 20.46 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 22.7 in Q4 2025 to a low of 9.18 in Q4 2024.